Testosterone replacement therapy and polycythemia in HIV-infected patients

AIDS

Volumn 26, Issue 2, 2012, Pages 243-245

  Vorkas, Charles Kyriakos ^a,b   Vaamonde, Carlos M ^a   Glesby, Marshall J ^a  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TESTOSTERONE;

ARTICLE; HEMOGLOBIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONITORING; POLYCYTHEMIA; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT;

ADMINISTRATION, CUTANEOUS; ANDROGENS; CASE-CONTROL STUDIES; HEMOGLOBINS; HIV SEROPOSITIVITY; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; ODDS RATIO; POLYCYTHEMIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TESTOSTERONE; TIME FACTORS;

EID: 84155170966     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834db446     Document Type: Article

References (13)

1. Edwards TB, Nelson RP, Ballester OF. Polycythemia as a complication of human immunodeficiency virus infection. South Med J 1993; 86:686-688.
2. Sassaki M, Siciliano C, Padilha A. Polycythemia vera in a patient with the human immunodeficiency virus: a case report. Brazil J Inf Dis 2000; 4:204-207.
3. Koduri PR, Sherer R, Teter C. Polycythemia in patients infected with human immunodeficiency virus-1. Am J Hematol 2000; 64:80-81.
4. Taha HM, Kaplan BH. Polycythemia vera in a patient with acquired immunodeficiency syndrome. Am J Hematol 1998; 58:248-249.
5. Barbone E, Girolami A, Randi ML. HIV infection and polycythemia vera: a relationship worth pursuing? J Med 1993; 24:409-410.
6. Battan R, Ottaviano P, Porcelli M, Distenfeld A. Polycythaemia in patient with AIDS. Lancet 1990; 335:1342-1343.
7. Willocks L, Ludlam CA, Welsby PD. Polycythemia and HIV infection. Lancet 1990; 336:812-813.
8. Kennedy CA, Griffith HS, Mathisen GE. Erythrocytosis after zidovudine for AIDS. Ann Int Med 1991; 114:250-251.
9. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA. Pharmacokinetics, efficacy and safety of a permeationenhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999; 84:3469-3478.
10. Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004; 350:482-492.
11. Ip FF, di Piero I, Brown R, Cunningham I, Handelsman DJ, Liu PY. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testostosterone pellets. Eur J Endocrinol 2010; 162:385-390.
12. Sagone AL Jr, Balcerzak SP. Smoking as a cause of erythrocytosis. Ann Intern Med 1975; 82:512-515.
13. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22:14-22.